131 related articles for article (PubMed ID: 9744395)
1. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.
Shibata M; Takekawa M; Amano S
Surg Today; 1998; 28(9):884-8. PubMed ID: 9744395
[TBL] [Abstract][Full Text] [Related]
2. Increased serum concentration of circulating soluble receptor for interleukin-2 and its effect as a prognostic indicator in cachectic patients with gastric and colorectal cancer.
Shibata M; Takekawa M
Oncology; 1999; 56(1):54-8. PubMed ID: 9885378
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of circadian fluctuations in serum concentration of cortisol and TNF-alpha soluble receptors in gastrointestinal cancer patients.
Zubelewicz-Szkodzinska B; Muc-Wierzgon M; Wierzgon J; Brodziak A
Oncol Rep; 2001; 8(1):207-12. PubMed ID: 11115600
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
[TBL] [Abstract][Full Text] [Related]
6. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
[TBL] [Abstract][Full Text] [Related]
7. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
Jabłońska E; Pietruska Z
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
[TBL] [Abstract][Full Text] [Related]
8. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis].
Kacprzyk F
Pol Arch Med Wewn; 2002 Mar; 107(3):215-21. PubMed ID: 12107979
[TBL] [Abstract][Full Text] [Related]
10. The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
Huang A; Quinn H; Glover C; Henderson DC; Allen-Mersh TG
Cancer Immunol Immunother; 2002 Mar; 51(1):53-7. PubMed ID: 11845260
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
[TBL] [Abstract][Full Text] [Related]
12. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
Nowak J; Rozentryt P; Szewczyk M; Gierlotka M; Duszańska A; Szyguła B; Wojnicz R; Hawranek M; Poloński L; Zembala M
Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
[TBL] [Abstract][Full Text] [Related]
13. The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery.
Slotwiński R; Olszewski WL; Chaber A; Slodkowski M; Zaleska M; Krasnodebski IW
J Clin Immunol; 2002 Sep; 22(5):289-96. PubMed ID: 12405162
[TBL] [Abstract][Full Text] [Related]
14. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
Haack M; Pollmächer T; Mullington JM
Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
[TBL] [Abstract][Full Text] [Related]
15. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
17. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
19. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
[TBL] [Abstract][Full Text] [Related]
20. Bacterial translocation contributes to cachexia from locally advanced gastric cancer.
Mi L; Lin J; Zheng H; Xu X; Zhang J; Zhang D
Hepatogastroenterology; 2012 Oct; 59(119):2348-51. PubMed ID: 22709824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
